27 02, 2023

Seagen Jumps 11% on Pfizer Acquisition Rumors – Should You Buy the Hype Early?

By |2023-12-07T21:00:34+00:00February 27th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , |

As Pfizer’s sales continue to struggle, they’ve turned to acquisitions as a means of making up for lost revenue. And one company they have their eye on is Seagen - a cancer drugmaker with a market cap of roughly $30 billion. Last year, Seagen was rumored to be acquired by Merck. This deal could [...]

6 02, 2023

Catalent is Up 22% Amidst Acquisition Rumors: Is the Stock Worth a Buy, Though?

By |2023-12-07T21:03:00+00:00February 6th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Catalent (CTLT) is all over the headlines this Monday morning as rumors surge of an acquisition. The buyer in question is Danaher (DHR), a company that designs and manufactures diagnostic tools for health, food, and water services. This play is said to be Danaher’s way of competing with Thermo Fisher Scientific. This marriage makes [...]

5 01, 2023

Jazz Up your Portfolio in 2023

By |2023-12-07T21:05:22+00:00January 5th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was founded in 2003 and is incorporated and headquartered in Dublin, Ireland. JAZZ is a fully integrated, global biopharmaceutical company whose stated purpose is to provide innovative solutions and life-changing drugs to transform the lives of patients and their families across the globe, and result in longer lives. The [...]

3 01, 2023

Should You Buy Amgen Stock as Dividends are Set to Increase? 3 Things You Need to Account For

By |2023-12-07T21:05:45+00:00January 3rd, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

Amgen, a company known for pioneering modern biotechnology, has released information indicating they will be increasing the dividend from what was paid out last year. Executives stated that the payment will be $2.13 - which is 3.2% of the stock price.  Compared to the industry average for dividend payouts, this is quite impressive. But [...]

11 11, 2022

Doximity Climbs 25% After Earnings Release & Buyback News – Here’s What Investors Should do Next…

By |2023-12-07T21:10:59+00:00November 11th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Doximity - a company that has been referred to as the “LinkedIn of medical professionals” is up over 25% so far today. The social networking site allows doctors to connect with patients for evaluations and check-ins, network with peers, stay up to date on news and research, and more. What happened that resulted in [...]

12 09, 2022

What Does General Electric’s (GE) New HealthCare Spinoff Mean for Investors?

By |2023-12-07T21:16:18+00:00September 12th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , |

It’s been a rough year for General Electric, as the company is down over 25% in the past year. The high-tech industrial firm operates in a wide array of sectors and is well diversified - and yet, they’ve struggled even in the bigger picture. In the past 5 years, GE is down a whopping 60%. [...]

Go to Top